Protease‐activated receptor‐mediated platelet aggregation in acute coronary syndrome patients on potent P2Y(12) inhibitors

BACKGROUND: Despite the increasing use of potent P2Y(12) inhibitors, further atherothrombotic events still impair the prognosis of many acute coronary syndrome (ACS) patients. This may in part be attributable to intact platelet aggregation via the human thrombin receptors protease‐activated receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Wadowski, Patricia P., Pultar, Joseph, Weikert, Constantin, Eichelberger, Beate, Panzer, Benjamin, Huber, Kurt, Lang, Irene M., Koppensteiner, Renate, Panzer, Simon, Gremmel, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles: Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611376/
https://www.ncbi.nlm.nih.gov/pubmed/31294325
http://dx.doi.org/10.1002/rth2.12213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611376/
https://www.ncbi.nlm.nih.gov/pubmed/31294325
http://dx.doi.org/10.1002/rth2.12213

Ejemplares similares